Picard Medical Securities Class Action Notice Issued
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy PMI?
Source: Globenewswire
- Class Action Initiation: Rosen Law Firm reminds investors who purchased Picard Medical (NYSE American: PMI) securities between September 2 and October 31, 2025, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- False Statements Uncovered: The lawsuit alleges that Picard Medical's management failed to disclose significant adverse facts regarding the company's business and securities trading during the class period, including a fraudulent stock promotion scheme involving social media misinformation and insider selling activities, misleading investors.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked No. 1 by ISS Securities Class Action Services in 2017, highlighting its success and expertise in this field.
- Investor Guidance: The firm advises investors to select qualified counsel with a proven track record, avoiding inexperienced middlemen, to ensure optimal legal support and potential recovery in the class action lawsuit.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PMI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PMI
About PMI
Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Picard Medical Securities Class Action Notice Issued
- Class Action Initiation: Rosen Law Firm reminds investors who purchased Picard Medical (NYSE American: PMI) securities between September 2 and October 31, 2025, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- False Statements Uncovered: The lawsuit alleges that Picard Medical's management failed to disclose significant adverse facts regarding the company's business and securities trading during the class period, including a fraudulent stock promotion scheme involving social media misinformation and insider selling activities, misleading investors.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked No. 1 by ISS Securities Class Action Services in 2017, highlighting its success and expertise in this field.
- Investor Guidance: The firm advises investors to select qualified counsel with a proven track record, avoiding inexperienced middlemen, to ensure optimal legal support and potential recovery in the class action lawsuit.
See More
Picard Medical Faces Class Action Over Fraudulent Stock Promotion Allegations
- Lawsuit Reminder: Robbins LLP reminds all investors who purchased or acquired Picard Medical (NYSE:PMI) securities between September 2, 2025, and October 31, 2025, that a class action has been filed, indicating potential losses for shareholders.
- Fraud Allegations: The complaint alleges that Picard Medical failed to disclose its involvement in a fraudulent stock promotion scheme utilizing social media misinformation and impersonated financial professionals, misleading investors significantly.
- Stock Price Crash: On October 24, 2025, Picard Medical's stock price plummeted by 70%, dropping from $13.30 to $3.99 per share, and has since continued to decline to approximately $2.00 per share, reflecting a severe crisis of market trust for the company.
- Shareholder Action: Shareholders can file papers by April 3, 2026, to serve as lead plaintiffs in the class action, representing other shareholders and highlighting the urgent need for improved corporate governance to protect investor rights.
See More
Class Action Lawsuit Reminder Against Picard Medical, Inc.
- Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against Picard Medical, Inc. (NYSE American:PMI) for securities transactions between September 2, 2025, and October 31, 2025, urging investors to contact the firm before April 3, 2026, to protect their rights.
- False Statement Allegations: The complaint alleges that Picard Medical made false and misleading statements during the class period, engaging in a manipulation scheme to fraudulently inflate its stock price, resulting in investor losses when the truth emerged, highlighting severe governance and transparency issues within the company.
- Shareholder Rights Protection: The Schall Law Firm specializes in securities class action lawsuits and encourages affected shareholders to reach out for free legal consultations, emphasizing the importance of legal assistance in safeguarding investor rights.
- Legal Proceedings Update: The class action has not yet been certified, meaning investors are not represented by an attorney during this period, and those who choose not to act will remain absent class members, reminding investors to stay informed about the legal process to protect their interests.
See More
Faruqi & Faruqi Investigates Investor Losses in Picard Medical
- Investor Loss Investigation: Faruqi & Faruqi LLP is investigating potential claims against Picard Medical, particularly for investors who suffered losses exceeding $50,000 between September 2, 2025, and October 31, 2025, aiming to provide legal support for affected investors.
- Legal Rights Consultation: The firm encourages impacted investors to contact partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal rights and possible claims options.
- Class Action Reminder: Faruqi & Faruqi reminds investors that a federal securities class action has been filed against Picard Medical, and investors must apply to be lead plaintiffs by April 13, 2026, to secure their rights in the lawsuit.
- Role of Securities Law Firm: As a leading national securities law firm, Faruqi & Faruqi is committed to protecting investor rights and investigating potential claims, demonstrating a strong commitment to addressing investor losses and providing legal support.
See More
Multiple Companies Facing Class Action Lawsuits
- Richtech Robotics Lawsuit: Richtech Robotics Inc. is facing allegations of false statements regarding a supposed collaboration with Microsoft during the class period from January 27 to January 29, 2026, misleading investors about the company's prospects, with a lead plaintiff deadline of April 3, 2026.
- Plug Power Lawsuit: Plug Power, Inc. is accused of overstating the availability of funds related to a DOE loan during the class period from January 17 to November 13, 2025, potentially forcing the company to pivot to smaller projects, with a lead plaintiff deadline of April 3, 2026.
- Picard Medical Lawsuit: Picard Medical, Inc. faces allegations of being involved in a fraudulent stock promotion scheme from September 2 to October 31, 2025, failing to disclose insider trading activities, with a lead plaintiff deadline of April 3, 2026.
- BlackRock TCP Capital Lawsuit: BlackRock TCP Capital Corp. is accused of failing to appropriately value investments during the class period from November 6, 2024, to January 23, 2026, leading to an overstated net asset value, with a lead plaintiff deadline of April 6, 2026.
See More
Multiple Companies Face Class Action Lawsuits
- Richtech Robotics Class Action: Richtech Robotics Inc. (NASDAQ:RR) faces a class action lawsuit for failing to disclose its non-existent collaboration with Microsoft during the class period from January 27 to January 29, 2026, with a lead plaintiff motion deadline of April 3, 2026, for affected investors.
- Picard Medical Allegations: Picard Medical, Inc. (NYSE:PMI) is implicated in a class action lawsuit for a fraudulent stock promotion scheme involving social media misinformation during the period from September 2 to October 31, 2025, requiring investors to act by April 3, 2026, to participate.
- Plug Power Misrepresentation: Plug Power, Inc. (NASDAQ:PLUG) is accused in a class action lawsuit of materially overstating the availability of funds from a DOE loan during the class period from January 17 to November 13, 2025, with a deadline for lead plaintiff motions set for April 3, 2026.
- Legal Firm Advisory: The Law Offices of Frank R. Cruz remind affected investors that participation in these class actions does not require immediate action, but they are encouraged to consult legal counsel to understand their rights and interests.
See More
Picard Medical Securities Class Action Notice Issued
- Class Action Initiation: Rosen Law Firm reminds investors who purchased Picard Medical (NYSE American: PMI) securities between September 2 and October 31, 2025, to apply as lead plaintiffs by April 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- False Statements Uncovered: The lawsuit alleges that Picard Medical's management failed to disclose significant adverse facts regarding the company's business and securities trading during the class period, including a fraudulent stock promotion scheme involving social media misinformation and insider selling activities, misleading investors.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked No. 1 by ISS Securities Class Action Services in 2017, highlighting its success and expertise in this field.
- Investor Guidance: The firm advises investors to select qualified counsel with a proven track record, avoiding inexperienced middlemen, to ensure optimal legal support and potential recovery in the class action lawsuit.
See More
Picard Medical Faces Class Action Over Fraudulent Stock Promotion Allegations
- Lawsuit Reminder: Robbins LLP reminds all investors who purchased or acquired Picard Medical (NYSE:PMI) securities between September 2, 2025, and October 31, 2025, that a class action has been filed, indicating potential losses for shareholders.
- Fraud Allegations: The complaint alleges that Picard Medical failed to disclose its involvement in a fraudulent stock promotion scheme utilizing social media misinformation and impersonated financial professionals, misleading investors significantly.
- Stock Price Crash: On October 24, 2025, Picard Medical's stock price plummeted by 70%, dropping from $13.30 to $3.99 per share, and has since continued to decline to approximately $2.00 per share, reflecting a severe crisis of market trust for the company.
- Shareholder Action: Shareholders can file papers by April 3, 2026, to serve as lead plaintiffs in the class action, representing other shareholders and highlighting the urgent need for improved corporate governance to protect investor rights.
See More
Class Action Lawsuit Reminder Against Picard Medical, Inc.
- Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against Picard Medical, Inc. (NYSE American:PMI) for securities transactions between September 2, 2025, and October 31, 2025, urging investors to contact the firm before April 3, 2026, to protect their rights.
- False Statement Allegations: The complaint alleges that Picard Medical made false and misleading statements during the class period, engaging in a manipulation scheme to fraudulently inflate its stock price, resulting in investor losses when the truth emerged, highlighting severe governance and transparency issues within the company.
- Shareholder Rights Protection: The Schall Law Firm specializes in securities class action lawsuits and encourages affected shareholders to reach out for free legal consultations, emphasizing the importance of legal assistance in safeguarding investor rights.
- Legal Proceedings Update: The class action has not yet been certified, meaning investors are not represented by an attorney during this period, and those who choose not to act will remain absent class members, reminding investors to stay informed about the legal process to protect their interests.
See More
Faruqi & Faruqi Investigates Investor Losses in Picard Medical
- Investor Loss Investigation: Faruqi & Faruqi LLP is investigating potential claims against Picard Medical, particularly for investors who suffered losses exceeding $50,000 between September 2, 2025, and October 31, 2025, aiming to provide legal support for affected investors.
- Legal Rights Consultation: The firm encourages impacted investors to contact partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal rights and possible claims options.
- Class Action Reminder: Faruqi & Faruqi reminds investors that a federal securities class action has been filed against Picard Medical, and investors must apply to be lead plaintiffs by April 13, 2026, to secure their rights in the lawsuit.
- Role of Securities Law Firm: As a leading national securities law firm, Faruqi & Faruqi is committed to protecting investor rights and investigating potential claims, demonstrating a strong commitment to addressing investor losses and providing legal support.
See More
Multiple Companies Facing Class Action Lawsuits
- Richtech Robotics Lawsuit: Richtech Robotics Inc. is facing allegations of false statements regarding a supposed collaboration with Microsoft during the class period from January 27 to January 29, 2026, misleading investors about the company's prospects, with a lead plaintiff deadline of April 3, 2026.
- Plug Power Lawsuit: Plug Power, Inc. is accused of overstating the availability of funds related to a DOE loan during the class period from January 17 to November 13, 2025, potentially forcing the company to pivot to smaller projects, with a lead plaintiff deadline of April 3, 2026.
- Picard Medical Lawsuit: Picard Medical, Inc. faces allegations of being involved in a fraudulent stock promotion scheme from September 2 to October 31, 2025, failing to disclose insider trading activities, with a lead plaintiff deadline of April 3, 2026.
- BlackRock TCP Capital Lawsuit: BlackRock TCP Capital Corp. is accused of failing to appropriately value investments during the class period from November 6, 2024, to January 23, 2026, leading to an overstated net asset value, with a lead plaintiff deadline of April 6, 2026.
See More
Multiple Companies Face Class Action Lawsuits
- Richtech Robotics Class Action: Richtech Robotics Inc. (NASDAQ:RR) faces a class action lawsuit for failing to disclose its non-existent collaboration with Microsoft during the class period from January 27 to January 29, 2026, with a lead plaintiff motion deadline of April 3, 2026, for affected investors.
- Picard Medical Allegations: Picard Medical, Inc. (NYSE:PMI) is implicated in a class action lawsuit for a fraudulent stock promotion scheme involving social media misinformation during the period from September 2 to October 31, 2025, requiring investors to act by April 3, 2026, to participate.
- Plug Power Misrepresentation: Plug Power, Inc. (NASDAQ:PLUG) is accused in a class action lawsuit of materially overstating the availability of funds from a DOE loan during the class period from January 17 to November 13, 2025, with a deadline for lead plaintiff motions set for April 3, 2026.
- Legal Firm Advisory: The Law Offices of Frank R. Cruz remind affected investors that participation in these class actions does not require immediate action, but they are encouraged to consult legal counsel to understand their rights and interests.
See More
